# Seroprevalence of SARS-Cov-2 Antibodies in Children

> **NCT04347408** · — · COMPLETED · sponsor: **Queen's University, Belfast** · enrollment: 1100 (actual)

## Conditions studied

- COVID
- Corona Virus Infection
- Multisystem Inflammatory Syndrome in Children

## Interventions

- **DIAGNOSTIC_TEST:** Covid-19 Antibody testing (IgG and IgM)
- **OTHER:** Blood Storage

## Key facts

- **NCT ID:** NCT04347408
- **Lead sponsor:** Queen's University, Belfast
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-06
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-11-14
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04347408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04347408, "Seroprevalence of SARS-Cov-2 Antibodies in Children". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04347408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*